CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | -37.7% | -100.0% | – | – | +185.6% | -86.1% | +4,208.4% | +74.2% | +134.0% | – | |
| – | +4.0% | -99.0% | +58.9% | +8,121.1% | +7.5% | -100.0% | – | +9,333.2% | -100.5% | – | -23.0% | – | |
| – | -13,273.4% | – | -37.7% | -15,615.0% | – | – | +185.6% | -86.1% | +4,208.4% | +71.0% | +137.0% | – | |
| – | +4.1% | +16.9% | +9.4% | +6.1% | +7.5% | +14.5% | +5.3% | +12.7% | -6.0% | +17.7% | -0.2% | – | |
| – | +10.3% | +22.0% | +19.3% | +4.2% | +8.8% | +26.1% | +40.3% | +4.9% | +2.7% | -5.3% | +13.3% | – | |
| – | -71.2% | +334.3% | +12.2% | -68.9% | +8.8% | +296.6% | +16.4% | +9.7% | -2.0% | +7.9% | +4.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.